Gaucher Disease: The Rare Genetic Disorder Often Missed

Gaucher disease, one of the most common lysosomal storage disorders, remains widely underdiagnosed in India and globally, despite being a treatable genetic condition. Caused by a deficiency of the enzyme glucocerebrosidase, the disease leads to the accumulation of fatty substances, or lipids, in vital organs such as the liver, spleen, bone marrow, and sometimes the brain. This progressive build-up disrupts normal organ function and can cause serious long-term complications if not identified early. “The condition occurs due to deficiency of the enzyme glucocerebrosidase, which leads to accumulation of fatty substances inside cells, particularly in the liver, spleen, bone marrow, and sometimes the nervous system,” said Dr. Furqan Khan, Consultant

Neurologist at Saifee Hospital.Also read: Heatwave Emergency Guide: What to Do When Someone Suddenly Collapses from Heatstroke

Why does Gaucher disease often get missed?

A major challenge in diagnosing Gaucher disease is that its symptoms closely resemble more common conditions like anemia, liver disease, or blood disorders. Patients frequently present with enlarged liver or spleen or splenomegaly, low hemoglobin levels, low platelet counts, bone pain, fatigue, and recurrent fractures. In children, warning signs may include growth delay and unexplained abdominal swelling. “Because these symptoms are nonspecific, many patients remain undiagnosed for years, delaying treatment and increasing the risk of complications,” said Dr. Khan. Experts stress that any patient with unexplained cytopenia, bone disease, or organ enlargement should be evaluated for Gaucher disease.

Types of Gaucher disease

Gaucher disease is classified into three main types based on neurological involvement:

Type 1 (Non-neuronopathic Gaucher disease)

The most common form affects the liver, spleen, and bones without brain involvement.

Type 2 (Acute neuronopathic Gaucher disease)

A rare and severe form seen in infants, marked by rapid neurological decline.

Type 3 (Chronic neuronopathic Gaucher disease)

A progressive condition involving both systemic and neurological symptoms.

The role of the GBA gene

Gaucher disease is an inherited genetic disorder caused by mutations in the GBA gene, passed down in an autosomal recessive pattern. This means a child must inherit the defective gene from both parents to develop the disease. Interestingly, studies suggest that nearly 1 in 100 people globally may be carriers, highlighting the need for genetic counselling and family screening when a case is diagnosed. “In India, awareness among clinicians and the public is still evolving. Because Gaucher disease is genetic and inherited in an autosomal recessive pattern, genetic counseling and family screening are essential once a case is diagnosed,” said Dr. Khan.

Treatment options: Why early diagnosis matters?

The good news is that Gaucher disease is treatable, especially when detected early. The two main treatment approaches include:

Enzyme Replacement Therapy (ERT)

It replaces the missing enzyme, helping reduce lipid accumulation and improve organ function.

Substrate Reduction Therapy (SRT):

Decreases the production of fatty substances, limiting their build-up in cells. These therapies can significantly improve quality of life, reverse organ enlargement, stabilize blood counts, and prevent irreversible complications when started on time.

Improving awareness in India

In India, awareness of Gaucher disease among both healthcare providers and the public is still evolving. However, advances in enzyme testing and genetic diagnostics are making early detection more accessible. Increasing awareness among clinicians is essential to ensure timely diagnosis, especially in patients with unexplained symptoms. Gaucher disease may be rare, but it is far from untreatable. With growing awareness, improved diagnostic tools, and effective therapies, early intervention can transform outcomes. Recognising the signs early and seeking timely medical evaluation can make the difference between prolonged suffering and a significantly improved quality of life.